Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?

Jean-Charles Fruchart, Raul D. Santos, Shizuya Yamashita, Peter Libby, Jean-Charles Fruchart, Raul D. Santos, Shizuya Yamashita, Masanori Aikawa, Peter Libby, Jorge Plutzky, Aruna Pradhan, Paul Ridker, Carlos Aguilar-Salinas, Khalid Al Rasadi, Pierre Amarenco, Philip J. Barter, Richard Ceska, Alberto Corsini, Massimiliano Ruscica, Jean-Pierre Després, Patrick Duriez, Robert H. Eckel, Marat V. Ezhov, Michel Farnier, Henry N. Ginsberg, Michel P. Hermans, Shun Ishibashi, Fredrik Karpe, Tatsuhiko Kodama, Wolfgang Koenig, Michel Krempf, Soo Lim, Alberto J. Lorenzatti, Ruth McPherson, Jesus Millan Nuñez-Cortes, Børge G. Nordestgaard, Hisao Ogawa, Chris J. Packard, Carlos I. Ponte-Negretti, Željko Reiner, Shaukat Sadikot, Hitoshi Shimano, Piyamitr Sritara, Jane K. Stock, Ta-Chen Su, Andrey V. Susekov, André Tartar, Marja-Riitta Taskinen, Alexander Tenenbaum, Lale S. Tokgözoğlu, Brian Tomlinson, Anne Tybjærg-Hansen, Paul Valensi, Michal Vrablík, Walter Wahli, Gerald F. Watts, Koutaro Yokote, Alberto Zambon

Open source

DOI: 10.1016/j.dsx.2019.05.034
Published: 2019-07
Container: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.dsx.2019.05.034,
  title = {Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?},
  author = {Jean-Charles Fruchart and Raul D. Santos and Shizuya Yamashita and Peter Libby and Jean-Charles Fruchart and Raul D. Santos and Shizuya Yamashita and Masanori Aikawa and Peter Libby and Jorge Plutzky and Aruna Pradhan and Paul Ridker and Carlos Aguilar-Salinas and Khalid Al Rasadi and Pierre Amarenco and Philip J. Barter and Richard Ceska and Alberto Corsini and Massimiliano Ruscica and Jean-Pierre Després and Patrick Duriez and Robert H. Eckel and Marat V. Ezhov and Michel Farnier and Henry N. Ginsberg and Michel P. Hermans and Shun Ishibashi and Fredrik Karpe and Tatsuhiko Kodama and Wolfgang Koenig and Michel Krempf and Soo Lim and Alberto J. Lorenzatti and Ruth McPherson and Jesus Millan Nuñez-Cortes and Børge G. Nordestgaard and Hisao Ogawa and Chris J. Packard and Carlos I. Ponte-Negretti and Željko Reiner and Shaukat Sadikot and Hitoshi Shimano and Piyamitr Sritara and Jane K. Stock and Ta-Chen Su and Andrey V. Susekov and André Tartar and Marja-Riitta Taskinen and Alexander Tenenbaum and Lale S. Tokgözoğlu and Brian Tomlinson and Anne Tybjærg-Hansen and Paul Valensi and Michal Vrablík and Walter Wahli and Gerald F. Watts and Koutaro Yokote and Alberto Zambon},
  year = {2019},
  journal = {Diabetes \&amp; Metabolic Syndrome: Clinical Research \&amp; Reviews},
  doi = {10.1016/j.dsx.2019.05.034},
  url = {https://doi.org/10.1016/j.dsx.2019.05.034}
}

RIS

TY  - JOUR
TI  - Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
AU  - Jean-Charles Fruchart
AU  - Raul D. Santos
AU  - Shizuya Yamashita
AU  - Peter Libby
AU  - Jean-Charles Fruchart
AU  - Raul D. Santos
AU  - Shizuya Yamashita
AU  - Masanori Aikawa
AU  - Peter Libby
AU  - Jorge Plutzky
AU  - Aruna Pradhan
AU  - Paul Ridker
AU  - Carlos Aguilar-Salinas
AU  - Khalid Al Rasadi
AU  - Pierre Amarenco
AU  - Philip J. Barter
AU  - Richard Ceska
AU  - Alberto Corsini
AU  - Massimiliano Ruscica
AU  - Jean-Pierre Després
AU  - Patrick Duriez
AU  - Robert H. Eckel
AU  - Marat V. Ezhov
AU  - Michel Farnier
AU  - Henry N. Ginsberg
AU  - Michel P. Hermans
AU  - Shun Ishibashi
AU  - Fredrik Karpe
AU  - Tatsuhiko Kodama
AU  - Wolfgang Koenig
AU  - Michel Krempf
AU  - Soo Lim
AU  - Alberto J. Lorenzatti
AU  - Ruth McPherson
AU  - Jesus Millan Nuñez-Cortes
AU  - Børge G. Nordestgaard
AU  - Hisao Ogawa
AU  - Chris J. Packard
AU  - Carlos I. Ponte-Negretti
AU  - Željko Reiner
AU  - Shaukat Sadikot
AU  - Hitoshi Shimano
AU  - Piyamitr Sritara
AU  - Jane K. Stock
AU  - Ta-Chen Su
AU  - Andrey V. Susekov
AU  - André Tartar
AU  - Marja-Riitta Taskinen
AU  - Alexander Tenenbaum
AU  - Lale S. Tokgözoğlu
AU  - Brian Tomlinson
AU  - Anne Tybjærg-Hansen
AU  - Paul Valensi
AU  - Michal Vrablík
AU  - Walter Wahli
AU  - Gerald F. Watts
AU  - Koutaro Yokote
AU  - Alberto Zambon
PY  - 2019
JO  - Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews
DO  - 10.1016/j.dsx.2019.05.034
UR  - https://doi.org/10.1016/j.dsx.2019.05.034
ER  -

APA

Fruchart, J., Santos, R. D., Yamashita, S., Libby, P., Fruchart, J., Santos, R. D., Yamashita, S., Aikawa, M., Libby, P., Plutzky, J., Pradhan, A., Ridker, P., Aguilar-Salinas, C., Rasadi, K. A., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Ruscica, M., Després, J., Duriez, P., Eckel, R. H., Ezhov, M. V., Farnier, M., Ginsberg, H. N., Hermans, M. P., Ishibashi, S., Karpe, F., Kodama, T., Koenig, W., Krempf, M., Lim, S., Lorenzatti, A. J., McPherson, R., Nuñez-Cortes, J. M., Nordestgaard, B. G., Ogawa, H., Packard, C. J., Ponte-Negretti, C. I., Reiner, Ž., Sadikot, S., Shimano, H., Sritara, P., Stock, J. K., Su, T., Susekov, A. V., Tartar, A., Taskinen, M., Tenenbaum, A., Tokgözoğlu, L. S., Tomlinson, B., Tybjærg-Hansen, A., Valensi, P., Vrablík, M., Wahli, W., Watts, G. F., Yokote, K., & Zambon, A. (2019). Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2019.05.034

Source records

crossref · retrieved 2026-09-24T20:58:50.980Z